APA (7th ed.) Citation

Kirkpatrick, K., Ellwood, J., & Walker, R. W. M. (2012). Mucopolysaccharidosis type I (Hurler syndrome) and anesthesia: The impact of bone marrow transplantation, enzyme replacement therapy, and fiberoptic intubation on airway management. Pediatric anesthesia, 22(8), 745-751. https://doi.org/10.1111/j.1460-9592.2012.03897.x

Chicago Style (17th ed.) Citation

Kirkpatrick, Katherine, James Ellwood, and Robert W. M. Walker. "Mucopolysaccharidosis Type I (Hurler Syndrome) and Anesthesia: The Impact of Bone Marrow Transplantation, Enzyme Replacement Therapy, and Fiberoptic Intubation on Airway Management." Pediatric Anesthesia 22, no. 8 (2012): 745-751. https://doi.org/10.1111/j.1460-9592.2012.03897.x.

MLA (9th ed.) Citation

Kirkpatrick, Katherine, et al. "Mucopolysaccharidosis Type I (Hurler Syndrome) and Anesthesia: The Impact of Bone Marrow Transplantation, Enzyme Replacement Therapy, and Fiberoptic Intubation on Airway Management." Pediatric Anesthesia, vol. 22, no. 8, 2012, pp. 745-751, https://doi.org/10.1111/j.1460-9592.2012.03897.x.